Search Results - "Péchery, A."

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial by Tao, Y., Biau, J., Sun, X.S., Sire, C., Martin, L., Alfonsi, M., Prevost, J.B., Modesto, A., Lafond, C., Tourani, J.M., Miroir, J., Kaminsky, M.C., Coutte, A., Liem, X., Chautard, E., Vauleon, E., Drouet, F., Ruffier, A., Ramee, J.F., Waksi, G., Péchery, A., Wanneveich, M., Guigay, J., Aupérin, A., Bourhis, J.

“…To evaluate potential synergistic effect of pembrolizumab with radiotherapy (RT) compared with a standard-of-care (SOC) cetuximab–RT in patients with locally…”
Get full text

LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial by Bourhis, J., Sire, C., Tao, Y., Martin, L., Alfonsi, M., Prevost, J.B., Rives, M., Lafond, C., Tourani, J.M., Biau, J., Geoffrois, L., Coutte, A., Liem, X., Vauleon, E., Drouet, F., Pechery, A., Guigay, J., Wanneveich, M., Aupérin, A., Sun, X.

Get full text

914MO Standard versus fractionated high dose cisplatin concomitant with radiotherapy in locally advanced head & neck squamous cell cancer (LA-HNSCC): Results of the GORTEC 2015-02 CisFRad randomized trial by Borel, C., Sun, X., Coutte, A., Bera, G., Zanetta, S., Alfonsi, M., Janoray, G., Chatellier, T., Garcia-Ramirez, M., Gherga, E., Hammoud, Y., Etienne-Selloum, N., Pechery, A., Girard-Calais, M.H., Velten, M., Pignon, J-P., Wanneveich, M., Bourhis, J.

Get full text

Standard versus fractionated high dose cisplatin concomitant with radiotherapy in locally advanced head & neck squamous cell cancer (LA-HNSCC): Results of the GORTEC 2015-02 CisFRad randomized trial by Borel, C., Sun, X., Coutte, Alexandre, Bera, G., Zanetta, S., Alfonsi, M., Janoray, G., Chatellier, T., Garcia-Ramirez, M., Gherga, E., Hammoud, Y., Etienne-Selloum, N., Pechery, A., Girard-Calais, M. H., Velten, M., Pignon, J-P., Wanneveich, M., Bourhis, J.

Get full text

Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 ``PembroRad'' randomized trial by Bourhis, J., Sire, C., Tao, Y., Martin, L., Alfonsi, M., Prevost, J. B., Rives, M., Lafond, C., Tourani, J. M., Biau, J., Geoffrois, L., Coutte, Alexandre, Liem, X., Vauleon, E., Drouet, F., Pechery, A., Guigay, J., Wanneveich, M., Auperin, A., Sun, X.

Get full text